Hepatitis Delta International Network (HDIN)
Worldwide, more than 250 million people are infected with the hepatitis B virus (HBV), and 15–20 million of these individuals are thought to be co-infected with the hepatitis delta virus (HDV).
To improve the current therapeutic options, a better understanding of the pathophysiology is essential. Reliable research in this direction is only possible with large patient study groups. However, given the geographic distribution of hepatitis delta, larger patient cohorts would only be possible through multicenter collaboration.
On the following pages you can find information on the Hepatitis Delta International Network (HDIN) and our actions, about the hepatitis delta virus and some additional information for physicians & scientists.